e-learning
resources
London 2016
Monday, 05.09.2016
Rifampicin resistance, MDRTB, and new drug treatments
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS)
Ionuț Pavel (Iași, Romania), Ionut Pavel, Ina Iuliana Macovei, Simona Péter, Daniela Diculencu, Florin Rusu-Cordunean, Bogdan Dragos Grigoriu
Source:
International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Session:
Rifampicin resistance, MDRTB, and new drug treatments
Session type:
Poster Discussion
Number:
1910
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ionuț Pavel (Iași, Romania), Ionut Pavel, Ina Iuliana Macovei, Simona Péter, Daniela Diculencu, Florin Rusu-Cordunean, Bogdan Dragos Grigoriu. Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS). Eur Respir J 2016; 48: Suppl. 60, 1910
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Detection of fluoroquinolones resistance mutations in
mycobacterium tuberculosis
by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Molecular fingerprinting of mycobacterium tuberculosis isolates in new cases of tuberculosis using mycobacterial interspersed repetitive unit–variable number tandem repeat genotyping (MIRU-VNTR) – Epidemiology of drug resistant tuberculosis in Greece
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Detection of fluoroquinolone resistance associated mutations in Mycobacterium tuberculosis by use of sequencing and TaqMan probes
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Side effect profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Genotypes of mycobacterium tuberculosis with pre-extended drug resistance in Belarus
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
23S rRNA mutations in linezolid-resistant clinical isolates of M. tuberculosis: A report of two cases
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Line probe assay (LiPA) based rapid detection of multiple drug resistent (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Molecular characterization of M. tuberculosis complex strains from a drug resistance survey in Albania
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Bioinformatics approach identified of novel genes of tuberculosis susceptibility
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
High proportion of fluoroquinolone mono-resistant
mycobacterium tuberculosis
(MTB) strains in Pakistan (2010-2012)
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Whole genome-sequencing of non-tuberculous mycobacteria
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak
Source: Eur Respir J, 51 (6) 1702313; 10.1183/13993003.02313-2017
Year: 2018
Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept